Founded on the belief that every person has the right to live a longer, healthier life, Hevolution Foundation is a global catalyst, partner, and convener on a mission to drive efforts to extend healthy human lifespan and understand the processes of aging. With a focus on aging as a treatable process, Hevolution Foundation aims to increase the number of aging-related treatments on the market, compress the timeline of drug development, and increase accessibility to therapeutics that extend healthy lifespan, also known as healthspan. A global non-profit organization headquartered in Riyadh with a North American hub and an annual budget of up to $1 billion, Hevolution Foundation plans to open offices in other global locations to support a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer.

SOLVE FSHD is a venture philanthropic organization established to catalyze innovation and accelerate key research in finding a cure for FSHD, established by renowned Canadian entrepreneur and philanthropist, Chip Wilson. The Wilson family has committed $100 million to kick-start funding into projects that support the organization’s mission to find a cure for FSHD by 2027. The goal of SOLVE FSHD is to find a solution that can slow down or stop muscle degeneration, increase muscle regeneration and strength, and improve the quality of life for those living with FSHD.

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.

The Academy for Health & Lifespan Research envisions a world where breakthroughs in longevity are accelerated and made accessible. This is achieved through the innovative collaboration of the most brilliant researchers, laboratories, academic institutions, regulators, and drug companies.

Afrolongevity is a nonprofit subsidiary project of Transdisciplinary Agora for Future Discussions (TAFFD) that avails systemic approaches for understanding, translating and educating Africans on the ethical methods of achieving a healthy life span.

"Inspiring a Cultural Change to Transform Human Health”

The Alliance for Longevity Science, Arts & Entertainment (ALSAE) — pronounced “All Say” — is a pioneering nonprofit organization dedicated to uniting science and culture to help advance the field working to cure and prevent the chronic disease of aging.

By merging the groundbreaking innovations of longevity science with the transformative power of arts and entertainment, ALSAE aims to inspire a global cultural shift—one that redefines how we understand aging, health, and the possibilities of medical progress.

Through collaborations with creators, storytellers, and scientists, ALSAE fosters cultural change and accelerates efforts to cure age-related diseases such as Alzheimer’s, cardiovascular disease, and cancer.

The Alzheimer’s Association stands as the foremost voluntary health organization in Alzheimer's care, support, and research. Its mission is centered on eliminating Alzheimer’s disease through advancing research, providing and enhancing care and support for those affected, and reducing the risk of dementia by promoting brain health. The Association envisions a world free from Alzheimer’s and all other forms of dementia.

The American Federation for Aging Research (AFAR) is a prominent non-profit organization dedicated to promoting healthy aging through biomedical research. Its main initiatives include funding diverse, innovative research on aging, encouraging more physicians to specialize in geriatric medicine, facilitating knowledge exchange among professionals, and informing the public about medical advancements for a longer, healthier life.

Under the vision of its Chairman, Dr. Prathap C. Reddy, the Apollo Hospitals Group revolutionized corporate healthcare in India. Over 25 years, it has grown into Asia's largest integrated private hospital group, with expertise spanning hospitals, clinics, health insurance, healthcare IT, telemedicine, education, pharmacy retail, and medical business process outsourcing. The group manages over 10,000 beds across 51 hospitals, 1,517 pharmacies, and 102 clinics. Notably, it was the first Indian hospital group to receive accreditation from the Joint Commission International, USA, with five of its hospitals in New Delhi, Bangalore, Chennai, Hyderabad, and Dhaka being JCI accredited. Apollo Hospitals is a leader in introducing cutting-edge technology, like 320 Slice CT, Cyber-knife, and Computer Navigated Surgery. It is renowned for its world-class clinical talent and patient care, attracting international patients for advanced procedures like liver transplants, cardiac, orthopedic, spine surgery, and cancer treatments. Additionally, Apollo Hospitals has launched Apollo Lifeline, offering services like appointment booking, diabetes management, and emergency.

Cecy Health Consult Ltd, a healthcare organization, is committed to transforming Africa's healthcare landscape. Their mission is to provide cities and communities across Africa with smart access to quality healthcare through continuous innovation. With a focus on leveraging technology and other innovative solutions, their goal is to overhaul and enhance healthcare in Africa. Their operations encompass public/community health service, clinical operations and management, medical equipment supply, representation for international health brands, and personal development training.

Cecy Health Consult is known for its high-quality, affordable healthcare that aligns with international standards, achieved by utilizing advanced technology and innovative solutions. They offer a wide range of services including access to the latest drugs, state-of-the-art treatment technology, digital support for clinical and patient administration, remote clinic services, and comprehensive emergency ambulance services. Their commitment to excellence and quality improvement is reflected in their reputation for high performance and ongoing enhancements to the services provided to their clients.

Collider Health, led by Tina Woods with over 25 years of experience in health and science, serves as an innovation engine in the health sector. It connects individuals and organizations, fostering fresh thinking and collaborative networks among corporates, startups, the third sector, and investors for sustainable impact. The company is at the forefront of addressing major trends driven by technology, aging demographics, and evolving market demands. It emphasizes the critical need for agility and evolving business models in healthcare, advocating for a blend of wellcare and sickcare innovations. Collider Health stands as a catalyst in a rapidly changing health landscape, where technology, citizen engagement, and emerging markets are reshaping health and wealth concepts.

Cure is a premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop their groundbreaking products and services from concept to commercialization. For more information, please visit wewillcure.com.

Foresight Institute is a leading think tank and public interest organization focused on transformative future technologies. Founded in 1986, its mission is to discover and promote the upsides, and help avoid the dangers, of nanotechnology, AI, biotech, and similar life-changing developments.

The International Conference on Frailty and Sarcopenia Research (ICFSR) has been held annually since 2011. In addition to hosting its annual congress, ICFSR also has an editorial initiative, The Journal of Frailty Aging (JFA). JFA is a peer-reviewed international journal that is published quarterly and “aimed at presenting articles that are related to research in the area of aging and age-related (sub)clinical conditions.” To learn more about or register for ICFSR, head to ICFSR.com. To access JFA, visit jfrailtyaging.com.

Kinexum, an international healthcare consulting group, specializes in regulatory strategy, clinical development, and commercialization. With a team of former senior FDA and industry experts, Kinexum offers comprehensive services in regulatory, clinical, manufacturing, and commercialization fields. Over the past decade, the group has assisted more than 300 companies worldwide, including in Europe, Asia, Australia, and the Americas. Known for delivering high-impact solutions across various therapeutic areas, Kinexum's in-house medical expertise spans diabetes, cardiology, immunology, oncology, and gastroenterology. The group's capabilities extend to pharmaceuticals, biotechnology, medical devices, diagnostics, botanicals, and nutraceuticals, leveraging a global network for clinical and regulatory strategy, pharmacology, toxicology, and other key areas to efficiently achieve valuation milestones.

The mission of The Kitalys Institute is to accelerate and promote the translation of scientific advances into material, accessible gains in public health. The Institute focuses on retaining mobility, alertness, health, and resilience, as well as preventing chronic diseases and safely delaying or reversing biological aging, emphasizing the importance of an alliance between science and public health policy. By leading this effort, The Kitalys Institute aims to preserve health, prevent disease, and prolong healthspan through advocating for a national public policy that supports scientific advancements, geroscience breakthroughs, and behavioral health for all.

The Longevity Biotechnology Association is a non-profit organization representing global leaders in geroscience and gerotherapeutics, focusing on the development of new medicines and therapies to prevent and cure, rather than merely manage, the health conditions of late life. The Association is driven by a shared belief that every person deserves a life that is healthy, full, and long.

Longevity Investors creates premier platforms to connect a selected audience of the most prominent investors in the field. Through high-level events like the Longevity Investors Conference in Gstaad and curated gatherings worldwide, our mission is to advance understanding, collaboration and investment in longevity science.

Methuselah Foundation is a biomedical charity established to incentivize scientific progress towards extending the healthy human lifespan. Methuselah Foundation incubates and sponsors mission-critical ventures, scientific research, and competition prizes to accelerate breakthroughs in healthy human life extension.

Spanning three acute hospitals, two community hospitals, three national centers, seven polyclinics, three family medicine clinics, and three health science institutions, the National University Health System (NUHS) in Singapore stands as a leading academic health system. It's driven by research and education, offering a unique and comprehensive ecosystem. NUHS is inspired by the patients and population it serves, leveraging its strong network of talents and resources across institutions to provide patient-centered care focused on improving health and driving transformation across primary, tertiary, and complex care levels. In collaboration with community partners, NUHS is committed to delivering "Incredible Care and Health, Together."

PMRI, a non-profit research institute, conducts scientific research to investigate the effects of diet and lifestyle choices on health and disease. The institute's work is rooted in compassion and dedication to service. PMRI achieves its mission through various initiatives: publishing research that informs medical practice and empowers individuals to take personal responsibility for their health, collaborating with leaders in the scientific community, and educating and training health professionals and the public about preventive medicine and the benefits of lifestyle change.

SENS Research Foundation works to develop, promote, and ensure widespread access to therapies that cure and prevent the diseases and disabilities of aging by comprehensively repairing the damage that builds up in our bodies over time. SRF is redefining the way the world researches and treats age-related ill health, while inspiring the next generation of biomedical scientists.

The Aoki Foundation has a primary goal of supporting organizations in the brain science and research areas, with a specific focus on regenerative medicine and brain preservation. Its vision is to see a world where degenerative brain diseases do not exist, and where science and technology play a direct role in extending the healthy lives of individuals and their loved ones.

The Clarke Center is dedicated to harnessing imagination as a crucial human ability to tackle the world's most significant challenges. Its vision is a world where individuals are trained, encouraged, and equipped to use their imagination for problem-solving to benefit humanity and the planet. Motivated by the legacy of Sir Arthur C. Clarke, the center combines a passion for science and technology with idealism, compassion, and a sense of adventure to address today's pressing challenges. Recognizing the neurodiversity of imagination, from divergent thinkers and dreamers to aphantasics who don't visualize mentally, the center values each contribution in solving grand challenges. The Clarke Center believes that with imagination, there are boundless possibilities for the planet.

The Longevity Prize is a series of prizes to award and accelerate progress in longevity and rejuvenation research. It was initiated by VitaDAO, funded through donations through a gitcoin quadratic don

The University of Utah Data Coordinating Center (DCC) is a full-service Academic Research Organization (ARO) that operates a comprehensive Clinical and Data Coordinating Center. Our mission is to accelerate the translation of research to the bedside.

We support investigators and sponsors in Academics, Government, and Industry with end-to-end expertise in research design, management, execution, and analysis. We strive to provide a frictionless customer experience, navigating the complexity of research impacting patient outcomes.

VitaDAO is a decentralized, community-owned collective dedicated to funding and advancing early-stage longevity science research. Its mission is to support researchers working to preempt the onset of age-related diseases and to bring new therapeutics to market that enable people to live longer, healthier lives.